SELECTIVE-INHIBITION OF MESOLIMBIC DOPAMINE RELEASE FOLLOWING CHRONIC ADMINISTRATION OF CLOZAPINE - INVOLVEMENT OF ALPHA-1-NORADRENERGIC RECEPTORS DEMONSTRATED BY INVIVO VOLTAMMETRY

被引:56
作者
LANE, RF
BLAHA, CD
RIVET, JM
机构
[1] UNIV OREGON, INST NEUROSCI, EUGENE, OR 97403 USA
[2] UNIV OREGON, DEPT CHEM, EUGENE, OR 97403 USA
关键词
D O I
10.1016/0006-8993(88)90390-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:398 / 401
页数:4
相关论文
共 29 条
[1]  
BALDESSARINI RJ, 1985, CHEMOTHERAPY PSYCHIA
[2]   CHRONIC TREATMENT WITH CLASSICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS DIFFERENTIALLY DECREASES DOPAMINE RELEASE IN STRIATUM AND NUCLEUS-ACCUMBENS INVIVO [J].
BLAHA, CD ;
LANE, RF .
NEUROSCIENCE LETTERS, 1987, 78 (02) :199-204
[3]   CHEMICALLY MODIFIED ELECTRODE FOR INVIVO MONITORING OF BRAIN CATECHOLAMINES [J].
BLAHA, CD ;
LANE, RF .
BRAIN RESEARCH BULLETIN, 1983, 10 (06) :861-864
[4]  
BLAHA CD, 1987, ADV BEHAV BIOL, P115
[5]   ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY [J].
BUNNEY, BS ;
GRACE, AA .
LIFE SCIENCES, 1978, 23 (16) :1715-1727
[6]  
CHIODO LA, 1983, J NEUROSCI, V3, P1607
[7]  
CHIODO LA, 1985, J NEUROSCI, V5, P2539
[8]  
DAVIS J, 1983, NEUROLEPTICS NEUROCH, P15
[9]  
FANN WE, 1976, AM J PSYCHIAT, V133, P940
[10]  
GESSA GL, 1981, APOMORPHINE OTHER DO, V1